Caricamento...
Antibody-drug conjugates: Intellectual property considerations
Antibody-drug conjugates are highly complex entities that combine an antibody, a linker and a toxin. This complexity makes them demanding both technically and from a regulatory point of view, and difficult to deal with in their patent aspects. This article discusses different issues of patent protec...
Salvato in:
| Pubblicato in: | MAbs |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966491/ https://ncbi.nlm.nih.gov/pubmed/26292154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1082019 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|